What Is a TIPS Procedure and When Is It Needed?

TIPS stands for Transjugular Intrahepatic Portosystemic Shunt — and despite the intimidating name, it's a procedure that can dramatically improve quality of life for patients with severe complications of portal hypertension. In simple terms, TIPS creates an artificial channel through your liver that allows blood to bypass the scarred tissue that's causing the pressure buildup — relieving the pressure that drives ascites, variceal bleeding, and other complications.

But TIPS is not a simple fix. It trades one set of problems (portal hypertension complications) for another set of risks (particularly hepatic encephalopathy). Understanding when TIPS is the right choice, what the procedure involves, and what to expect afterward is essential for making an informed decision with your transplant team.

How TIPS works — the plumbing explained

In cirrhosis, scar tissue blocks blood flow through your liver. Blood coming from your intestines through the portal vein can't pass through efficiently — creating a pressure backup (portal hypertension) that causes ascites, varices, and splenomegaly.

TIPS solves this by creating a shortcut. An interventional radiologist threads a catheter through your jugular vein (in your neck), down through the hepatic vein, and into your liver. Using a special needle, they create a tunnel through the liver tissue connecting the portal vein to the hepatic vein. A metal mesh stent is placed in this tunnel to hold it open. Now blood from the portal system can flow directly into the hepatic vein — bypassing the scarred liver tissue and relieving the pressure.

The immediate effect is dramatic: portal pressure drops significantly, often within minutes. Ascites begins resolving within days to weeks. Variceal pressure drops, reducing bleeding risk. The physical relief — being able to breathe, eat, and move without the burden of liters of fluid — can be transformative.

When TIPS is recommended

TIPS isn't a first-line treatment. It's reserved for patients whose complications can't be adequately managed with medications and standard procedures:

Refractory ascites

This is the most common indication. Refractory ascites means your ascites doesn't respond to maximum-dose diuretics (spironolactone 400 mg + furosemide 160 mg) and sodium restriction, or you can't tolerate diuretics due to kidney injury, electrolyte imbalances, or encephalopathy. Patients requiring paracentesis every 1–2 weeks to manage fluid are candidates for TIPS — which can eliminate or dramatically reduce the need for repeated drainage procedures.

Recurrent variceal bleeding

If esophageal or gastric varices continue to bleed despite endoscopic banding and beta-blocker therapy, TIPS directly reduces the portal pressure driving the bleeding. It's also used as a rescue procedure during acute variceal hemorrhage that can't be controlled endoscopically.

Hepatic hydrothorax

Fluid that crosses from the abdominal cavity through defects in the diaphragm into the chest (pleural space) — causing shortness of breath. When this doesn't respond to diuretics and sodium restriction, TIPS can resolve it by reducing ascites production.

Budd-Chiari syndrome

Hepatic vein thrombosis (clotting in the veins that drain the liver) — TIPS can bypass the obstruction and restore hepatic blood flow.

The procedure: what actually happens

Before

Pre-procedure workup includes labs (liver function, clotting studies, kidney function), cardiac evaluation (echocardiogram — TIPS increases blood return to the heart, which can stress an already-compromised heart), and imaging (CT or MRI of the liver to plan the shunt route). You'll fast for 6–8 hours. The procedure is typically done under conscious sedation or general anesthesia.

During (1–3 hours)

An interventional radiologist performs the procedure in an angiography suite (not a standard operating room). A catheter is inserted through the jugular vein in your neck (under local anesthesia and sedation — you won't feel the internal part). The catheter is threaded through the superior vena cava, into the right atrium of your heart, and down into the hepatic vein inside your liver. Using fluoroscopic guidance (real-time X-ray), the radiologist advances a special needle through the liver tissue from the hepatic vein to the portal vein — creating the tunnel. A stent-graft (covered metal mesh tube, typically 8–10 mm diameter) is deployed in the tunnel to keep it open. Portal pressure is measured before and after to confirm the shunt is working — the target is a hepatic venous pressure gradient (HVPG) below 12 mmHg, or at least a 50% reduction from baseline.

After

You'll be monitored in the hospital for 1–3 days. Ultrasound is performed within 24 hours to confirm shunt patency (blood flowing through). Ascites, if present, begins improving within days — though complete resolution may take several weeks. Diuretics are continued initially and then gradually reduced or discontinued as the ascites resolves. Follow-up ultrasound every 3–6 months monitors shunt function (stenosis or occlusion can develop).

The trade-off: hepatic encephalopathy

This is the most significant complication of TIPS, and it's important to understand it clearly before proceeding.

TIPS works by diverting portal blood past the liver. This relieves portal pressure — but it also means that blood containing ammonia and other toxins from your intestines bypasses the liver's filtering function and goes directly into your systemic circulation. The result: new-onset or worsened hepatic encephalopathy occurs in approximately 25–45% of patients after TIPS.

For most patients, post-TIPS HE is manageable with lactulose and rifaximin. But for some, it becomes refractory — persistent confusion, personality changes, and cognitive impairment that significantly impairs quality of life. In these cases, the shunt diameter can be reduced (using a reducing stent) or, rarely, the shunt can be occluded — trading the HE improvement for return of the ascites or bleeding risk.

This is why TIPS requires careful patient selection: patients with pre-existing HE that's poorly controlled, very advanced liver dysfunction (Child-Pugh class C with high scores), severe cardiac disease, or very high MELD scores may not be good TIPS candidates — the risk of post-procedure decompensation outweighs the benefit.

Your hepatologist and interventional radiologist will discuss your specific risk profile in detail before proceeding. If you have concerns about HE risk, ask specifically: "What's my estimated risk of developing encephalopathy after TIPS, and how would we manage it?"

Other risks and complications

• Shunt stenosis or occlusion — the shunt can narrow or clot over time, particularly with older bare-metal stents. Modern covered stents (ePTFE-covered) have significantly lower stenosis rates (~15–20% at 1 year vs ~50% with bare stents). Regular ultrasound surveillance detects this early, and re-intervention (balloon angioplasty or stent revision) can restore function.

• Liver function deterioration — diverting blood away from the liver can worsen hepatic synthetic function in patients with already-marginal liver reserve. Bilirubin may rise. Albumin may fall. This is why TIPS in patients with very advanced liver disease (MELD >18–20) carries higher risk and requires careful judgment.

• Heart failure exacerbation — TIPS increases venous return to the heart (more blood flowing through the shortcut). In patients with pre-existing cardiac dysfunction, this can push the heart into failure. Pre-TIPS cardiac evaluation is essential.

• Procedural complications — bleeding, infection, liver capsule perforation, stent migration — all uncommon at experienced centers but possible. The 30-day mortality from the procedure itself is approximately 1–3%.

TIPS as a bridge to transplant

In many cases, TIPS is not intended as a permanent solution — it's a bridge to liver transplant. It buys time by controlling the complications that are making you sick (ascites, bleeding) while you wait on the transplant list for a new liver.

After transplant, the TIPS becomes irrelevant — the new liver has no scar tissue, portal pressure normalizes, and the shunt is no longer needed (it remains in place physically but stops carrying significant flow as normal liver circulation is restored).

For patients who are not transplant candidates, TIPS serves as long-term palliation — controlling complications and improving quality of life even without the prospect of transplant.

Life after TIPS: what changes

• Ascites improves or resolves in the majority of patients. Diuretics can often be reduced or stopped. Paracentesis frequency drops dramatically or becomes unnecessary. The relief from not carrying liters of abdominal fluid is one of the most immediate quality-of-life improvements in cirrhosis care.

• Variceal bleeding risk drops significantly. Portal pressure reduction means less blood being forced through collateral vessels. Beta-blockers and banding may still be continued but the overall bleeding risk is much lower.

• Nutritional status may improve. With ascites controlled, patients can often eat more comfortably (less early satiety from fluid pressing on the stomach), which improves caloric and protein intake — combating the sarcopenia that worsens outcomes.

• HE monitoring becomes essential. Lactulose compliance (2–3 soft stools per day) and rifaximin are typically prescribed prophylactically after TIPS. Daily bowel movement tracking, sleep pattern monitoring, and caregiver vigilance for confusion become part of the daily routine. Log everything in LiverTracker's HE monitoring system.

• Regular ultrasound surveillance. Every 3–6 months to check shunt patency. A narrowing or clotted shunt means the portal pressure rises again and complications can return. Report any recurrence of ascites or other symptoms between scheduled scans. Log every imaging result in the imaging tracker.

Continue uploading every lab report to LiverTracker. Your bilirubin, albumin, creatinine, sodium, and INR trends tell the story of how your liver is responding to the shunt — and whether the shunt is helping or whether the diversion is stressing your remaining liver function. Share your complete record with your hepatologist and interventional radiologist at every follow-up.

Who should NOT get TIPS

TIPS is not appropriate for every patient with portal hypertension complications. Contraindications include:

• Severe heart failure (right-sided or biventricular) — TIPS increases cardiac preload and can precipitate decompensated heart failure.

• Severe uncontrolled hepatic encephalopathy — TIPS will almost certainly make it worse.

• Very advanced liver disease (MELD >18–20, bilirubin >5, or Child-Pugh score >13) — the risk of post-TIPS liver failure exceeds the benefit in most cases.

• Active infection or sepsis

• Complete portal vein thrombosis (in some cases — partial thrombosis can sometimes be crossed)

• Polycystic liver disease (technical difficulty due to liver architecture)

• Severe pulmonary hypertension (mean PAP >45 mmHg)

Frequently asked questions

How long does a TIPS last?

Modern covered stents (ePTFE-covered) have primary patency rates of approximately 80–85% at one year. Stenosis or occlusion can develop over time, requiring re-intervention (balloon angioplasty or stent revision). With surveillance ultrasound every 3–6 months and timely intervention for stenosis, TIPS can function for years. For patients awaiting transplant, TIPS only needs to last until the new liver arrives. For long-term palliation, regular maintenance keeps the shunt functional.

Will TIPS make me confused?

Approximately 25–45% of patients develop new or worsened hepatic encephalopathy after TIPS. In most cases, this is manageable with lactulose and rifaximin. Severe, refractory post-TIPS HE occurs in a smaller subset and may require shunt reduction. Your pre-TIPS risk for HE depends on your baseline liver function, age, and prior HE history — discuss your specific risk with your team.

Is TIPS a surgery?

No — TIPS is a minimally invasive procedure performed by an interventional radiologist through a needle puncture in your neck (jugular vein access). No abdominal incision is needed. It's done under sedation or general anesthesia in an angiography suite, not an operating room. Hospital stay is typically 1–3 days. Recovery is much faster than traditional surgery.

Can TIPS cure cirrhosis?

No — TIPS treats the complications of cirrhosis (ascites, variceal bleeding), not the cirrhosis itself. The scarring in your liver remains. The underlying cause of your liver disease still needs treatment (alcohol abstinence, antiviral therapy, weight management). TIPS is a management tool — often a bridge to transplant — not a cure.

What if my shunt clots?

Shunt stenosis or occlusion is detected by surveillance ultrasound (every 3–6 months) and often suspected clinically when ascites recurs or other symptoms return. Treatment is typically endovascular — a catheter-based procedure to reopen or revise the shunt (balloon angioplasty, restenting). This is usually a same-day outpatient procedure and restores shunt function.

Does TIPS affect my MELD score or transplant eligibility?

TIPS itself doesn't directly change your MELD score — MELD is calculated from bilirubin, INR, creatinine, and sodium. However, if TIPS causes liver function to deteriorate (bilirubin rises, INR worsens) or if kidney function declines post-TIPS, your MELD may increase — which actually increases your transplant priority. TIPS does not disqualify you from transplant. In fact, TIPS is often placed specifically to manage complications while waiting for transplant.

TIPS is not a simple fix — it's a carefully calculated trade-off. It exchanges the misery of refractory ascites or recurrent bleeding for a manageable (but real) risk of encephalopathy. For the right patient at the right time, that trade-off is transformative.

→ Calculate Your MELD Score Free

→ Start Tracking Free

→ Log Your Imaging Results

Medical Disclaimer: This article is for informational and educational purposes only. TIPS decisions are complex and should be made by your hepatologist and interventional radiologist based on your specific clinical situation. Visit livertracker.com/medical-disclaimer.